<?xml version="1.0" encoding="UTF-8"?>
<p>A threshold survey was performed according to WHO guideline in the capital Addis Ababa, the city where ART was first started in Ethiopia, among treatment naïve women attending antenatal clinics in 2005. This survey revealed no major drug resistance for any available HIV drug class [
 <xref rid="pone.0205446.ref021" ref-type="bibr">21</xref>]. A nationwide study 2009–2011 indicated a pretreatment DR (PDR) level of 3.9%[
 <xref rid="pone.0205446.ref022" ref-type="bibr">22</xref>]. Moreover, three studies evaluated PDR among patients in Gondar (located in Northern Ethiopia) [
 <xref rid="pone.0205446.ref023" ref-type="bibr">23</xref>–
 <xref rid="pone.0205446.ref025" ref-type="bibr">25</xref>]., Even though these studies were not performed according to the WHO threshold surveillance method, they indicated an increase of PDR after ART roll out in the country.
</p>
